Table 2. Participant cancer and cancer treatment history (n = 126).
Genotype | ||||
---|---|---|---|---|
E2− | E2+ | E4− | E4+ | |
Cancer type | n (%) | |||
Breast | 77 (71) | 10 (59) | 67 (69) | 20 (69) |
Cervical | 3 (3) | 0 (0) | 1 (1) | 2 (7) |
Colon | 6 (6) | 2 (12) | 6 (6) | 2 (7) |
Lung | 3 (3) | 2 (12) | 5 (5) | 0 (0) |
Lymphoma | 5 (5) | 1 (6) | 4 (4) | 2 (7) |
Ovarian | 6 (6) | 1 (6) | 6 (6) | 1 (3) |
Uterine | 5 (5) | 1 (6) | 4 (4) | 2 (7) |
Other | 4 (4) | 0 (0) | 4 (4) | 0 (0) |
Cancer stage | ||||
I | 29 (27) | 6 (35) | 24 (25) | 11 (38) |
II | 39 (36) | 4 (24) | 34 (35) | 9 (31) |
III | 30 (28) | 5 (29) | 30 (31) | 5 (17) |
IV or metastatic | 0 (0%) | 0 (0) | 0 (0%) | 0 (0) |
No stage/don’t remember | 11 (10) | 2 (12) | 9 (9) | 4 (14) |
Cancer treatment received | 108 (99) | 16 (94) | 96 (99) | 28 (97) |
Chemotherapy | 109 (100) | 17 (100) | 97 (100) | 29 (100) |
Surgery | 99 (91) | 13 (76) | 85 (88) | 27 (93) |
Radiation | 74 (68) | 9 (53) | 63 (65) | 20 (69) |
Hormone therapy | 40 (37) | 3 (18) | 33 (34) | 10 (34) |
Diagnosed with any other type of cancer? | 21 (19) | 3 (18) | 21 (22) | 3 (10) |
Total | 109 (100) | 17 (100) | 97 (100) | 29 (100) |